What is it about?
Advances in the production of nanoparticles with tailored characteristics are said to offer a wide range of applications in oncological illness diagnosis and therapy using optical and multimodal imaging. Engineered fluorescent nanoparticles offer significant potential for high contrast images and targeted therapeutic applications among several nanoparticle-assisted imaging approaches.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Gold nanoparticles, carbon dots, and upconversion nanoparticles have lately emerged as the most promising prospects for cancer diagnosis, therapy, and monitoring out of all the fluorescent nanoparticles available.
Perspectives
The current development in tailoring the characteristics of these developing nanoparticles, as well as their use for cancer diagnostics and therapy, is discussed in this review. In addition, the potential for subcellular imaging of these particles is discussed.
Mr. AJINKYA NITIN NIKAM
Manipal College of Pharmaceutical Sciences, Manipal
Read the Original
This page is a summary of: Subcellular imaging and diagnosis of cancer using engineered nanoparticles, Current Pharmaceutical Design, May 2021, Bentham Science Publishers,
DOI: 10.2174/1381612827666210525154131.
You can read the full text:
Contributors
The following have contributed to this page
